These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Immune dysregulation in sepsis: experiences, lessons and perspectives. Cao M; Wang G; Xie J Cell Death Discov; 2023 Dec; 9(1):465. PubMed ID: 38114466 [TBL] [Abstract][Full Text] [Related]
24. IL-7 and Its Beneficial Role in Sepsis-Induced T Lymphocyte Dysfunction. de Roquetaillade C; Monneret G; Gossez M; Venet F Crit Rev Immunol; 2018; 38(6):433-451. PubMed ID: 31002599 [TBL] [Abstract][Full Text] [Related]
25. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid. Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Schunck WH; Falck JR; Malik KU Antiinflamm Antiallergy Agents Med Chem; 2012; 11(2):121-50. PubMed ID: 23013331 [TBL] [Abstract][Full Text] [Related]
26. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. Matsuda A; Jacob A; Wu R; Aziz M; Yang WL; Matsutani T; Suzuki H; Furukawa K; Uchida E; Wang P J Nippon Med Sch; 2012; 79(1):4-18. PubMed ID: 22398786 [TBL] [Abstract][Full Text] [Related]
28. Regulatory T Cells: Angels or Demons in the Pathophysiology of Sepsis? Gao YL; Yao Y; Zhang X; Chen F; Meng XL; Chen XS; Wang CL; Liu YC; Tian X; Shou ST; Chai YF Front Immunol; 2022; 13():829210. PubMed ID: 35281010 [TBL] [Abstract][Full Text] [Related]
30. An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach. Mokhtari B; Yavari R; Badalzadeh R; Mahmoodpoor A Can J Infect Dis Med Microbiol; 2022; 2022():3277274. PubMed ID: 35706715 [TBL] [Abstract][Full Text] [Related]
31. Biomarkers of inflammation and the etiology of sepsis. Grondman I; Pirvu A; Riza A; Ioana M; Netea MG Biochem Soc Trans; 2020 Feb; 48(1):1-14. PubMed ID: 32049312 [TBL] [Abstract][Full Text] [Related]
32. The Impact of Pathogens on Sepsis Prevalence and Outcome. Dyck B; Unterberg M; Adamzik M; Koos B Pathogens; 2024 Jan; 13(1):. PubMed ID: 38276162 [TBL] [Abstract][Full Text] [Related]
34. Metabolism and Nutrition in Sepsis: In Need of a Paradigm Shift. Collins K; Huen SC Nephron; 2023; 147(12):733-736. PubMed ID: 37703850 [TBL] [Abstract][Full Text] [Related]
35. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy. Vazquez-Grande G; Kumar A Semin Respir Crit Care Med; 2015 Feb; 36(1):154-66. PubMed ID: 25643278 [TBL] [Abstract][Full Text] [Related]
36. Sepsis: the inflammatory foundation of pathophysiology and therapy. Li J; Carr B; Goyal M; Gaieski DF Hosp Pract (1995); 2011 Aug; 39(3):99-112. PubMed ID: 21881397 [TBL] [Abstract][Full Text] [Related]
37. Sepsis Management in Southeast Asia: A Review and Clinical Experience. Mehta Y; Paul R; Rabbani R; Acharya SP; Withanaarachchi UK J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806919 [TBL] [Abstract][Full Text] [Related]
38. Changing Definitions of Sepsis. Gül F; Arslantaş MK; Cinel İ; Kumar A Turk J Anaesthesiol Reanim; 2017 Jun; 45(3):129-138. PubMed ID: 28752002 [TBL] [Abstract][Full Text] [Related]
39. Fluid Therapy in Dogs and Cats With Sepsis. Montealegre F; Lyons BM Front Vet Sci; 2021; 8():622127. PubMed ID: 33718468 [TBL] [Abstract][Full Text] [Related]